Invention Grant
US09175040B2 Immunotherapeutic peptides against neuronal and brain tumors and related methods and compositions
有权
针对神经元和脑肿瘤的免疫治疗肽及相关方法和组合物
- Patent Title: Immunotherapeutic peptides against neuronal and brain tumors and related methods and compositions
- Patent Title (中): 针对神经元和脑肿瘤的免疫治疗肽及相关方法和组合物
-
Application No.: US12180170Application Date: 2008-07-25
-
Publication No.: US09175040B2Publication Date: 2015-11-03
- Inventor: Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffen Walter , Harpreet Singh
- Applicant: Toni Weinschenk , Oliver Schoor , Claudia Trautwein , Norbert Hilf , Steffen Walter , Harpreet Singh
- Applicant Address: DE Tuebingen
- Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee: IMMATICS BIOTECHNOLOGIES GMBH
- Current Assignee Address: DE Tuebingen
- Agency: Miles and Stockbridge
- Priority: EP07014797 20070727; EP08005889 20080327
- Main IPC: C07K7/08
- IPC: C07K7/08 ; C07K7/06 ; A61K38/00
Abstract:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 11 novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
Public/Granted literature
- US20090123489A1 NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS Public/Granted day:2009-05-14
Information query
